Skip to main content
. 2018 Jan 23;14:1744806917751322. doi: 10.1177/1744806917751322

Figure 4.

Figure 4.

Effect of CCR2 antagonist (INCB3344) on diabetes-induced gastric hyperalgesia. Gastric sensitivity was measured in the control (CT) and diabetic (DM) rats at two weeks after STZ administration. The CCR2 antagonist INCB3344 (CCR2-A) or vehicle (veh) was injected intrathecally. Data are shown as mean ± SEM, #p < 0.01, p < 0.05 veh versus CCR2-A, n = 5–7 rats per group. INCB3344 (1 mM and 0.1 mM) significantly suppressed distension-induced gastric hyperalgesia in DM rats at 1 and 2 h after administration as compared with vehicle-treated rats.